These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 17944569)

  • 1. Significance and management of micrometastases in patients with breast cancer.
    Mittendorf EA; Hunt KK
    Expert Rev Anticancer Ther; 2007 Oct; 7(10):1451-61. PubMed ID: 17944569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Detailed pathological examination of the sentinel lymph nodes in order to detect micrometastases: no clinical relevance in patients with breast cancer].
    Meijnen P; Peterse JL; Nieweg OE; Rutgers EJ
    Ned Tijdschr Geneeskd; 2004 Dec; 148(49):2428-32. PubMed ID: 15626306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on the NSABP and ACOSOG breast cancer sentinel node trials.
    White RL; Wilke LG
    Am Surg; 2004 May; 70(5):420-4. PubMed ID: 15156950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological significance of occult micrometastases in histologically negative axillary lymph nodes in breast cancer patients using the recent American Joint Committee on Cancer breast cancer staging system.
    Kahn HJ; Hanna WM; Chapman JA; Trudeau ME; Lickley HL; Mobbs BG; Murray D; Pritchard KI; Sawka CA; McCready DR; Marks A
    Breast J; 2006; 12(4):294-301. PubMed ID: 16848838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic relevance of breast cancer micrometastases in sentinel lymph nodes.
    Noguchi M
    Br J Surg; 2002 Dec; 89(12):1505-15. PubMed ID: 12445058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical significance of axillary lymph node micrometastases in breast cancer.
    Sakorafas GH; Geraghty J; Pavlakis G
    Eur J Surg Oncol; 2004 Oct; 30(8):807-16. PubMed ID: 15336724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sentinel node biopsy: interpretation and management of patients with immunohistochemistry-positive sentinel nodes and those with micrometastases.
    Rutgers EJ
    J Clin Oncol; 2008 Feb; 26(5):698-702. PubMed ID: 18258976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The evolution of lymph node assessment in breast cancer.
    Quan ML; McCready D
    J Surg Oncol; 2009 Mar; 99(4):194-8. PubMed ID: 19021226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Strategies for management of axillary lymph nodes in breast cancer. Point of view of the Institut Bergonié. ].
    de Mascarel I; MacGrogan G
    Ann Pathol; 2003 Dec; 23(6):518-33. PubMed ID: 15094590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of sentinel lymph nodes in breast cancer.
    Cserni G
    Histopathology; 2005 Jun; 46(6):697-702. PubMed ID: 15910602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minimal axillary lymph node involvement in breast cancer has different prognostic implications according to the staging procedure.
    Montagna E; Viale G; Rotmensz N; Maisonneuve P; Galimberti V; Luini A; Intra M; Veronesi P; Mazzarol G; Pruneri G; Renne G; Torrisi R; Cardillo A; Cancello G; Goldhirsch A; Colleoni M
    Breast Cancer Res Treat; 2009 Nov; 118(2):385-94. PubMed ID: 19562480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic implications of isolated tumor cells and micrometastases in sentinel nodes of patients with invasive breast cancer: 10-year analysis of patients enrolled in the prospective East Carolina University/Anne Arundel Medical Center Sentinel Node Multicenter Study.
    Reed J; Rosman M; Verbanac KM; Mannie A; Cheng Z; Tafra L
    J Am Coll Surg; 2009 Mar; 208(3):333-40. PubMed ID: 19317993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The sentinel node in invasive breast cancer. Unsolved questions and review of the national and international clinical trials].
    Rodier JF
    Cancer Radiother; 2004 Feb; 8(1):29-32. PubMed ID: 15093198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of micrometastatic disease in sentinel lymph node in breast cancer.
    Rovera F; Frattini F; Chiappa C; Piscopo C; Bianchi V; Dionigi G; Rausei S; Boni L; Dionigi R
    Breast J; 2010; 16 Suppl 1():S26-8. PubMed ID: 21050305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
    Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
    Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of occult axillary lymph node metastases after chemotherapy-induced pathologic complete response of cytologically proven axillary lymph node metastases from breast cancer.
    Loya A; Guray M; Hennessy BT; Middleton LP; Buchholz TA; Valero V; Sahin AA
    Cancer; 2009 Apr; 115(8):1605-12. PubMed ID: 19197997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone marrow micrometastases and adjuvant treatment of breast cancer.
    Yu JJ; Brennan M; Christos P; Osborne MP; Hoda S; Simmons RM
    Breast J; 2004; 10(3):181-5. PubMed ID: 15125741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sentinel lymph node reevaluation].
    Siewert JR
    Chirurg; 2004 Aug; 75(8):749-50. PubMed ID: 15515215
    [No Abstract]   [Full Text] [Related]  

  • 19. Sentinel lymph node biopsy after neoadjuvant systemic chemotherapy in patients with breast cancer: a prospective pilot trial.
    Medina-Franco H; Salgado-Nesme N; Zerón-Medina-Cuairán J
    Rev Invest Clin; 2008; 60(5):390-4. PubMed ID: 19227436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Axillary recurrence rate after tumour negative and micrometastatic positive sentinel node procedures in breast cancer patients, a population based multicenter study.
    Bulte CS; van der Heiden-van der Loo M; Hennipman A
    Eur J Surg Oncol; 2009 Jan; 35(1):25-31. PubMed ID: 18640809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.